Life Sciences

SimBioSys, a TechBio company unlocking the power of spatial biophysics with artificial intelligence (AI) and biophysical modeling to redefine precision medicine for cancer, announced...

Pan-cancer study showed MTM/mL dynamics were more predictive of therapy response than mVAF dynamics, with an observed hazard ratio nearly 2x higher Natera, Inc., a...

The collaboration seeks to produce novel off-the-shelf TCR-based bispecific molecules designed to overcome current limitations in cell therapy approaches against solid tumors ImmunoScape, a biotechnology...

Fauna Bio, a biotechnology company improving human health by leveraging animal genomics, announced a multi-year agreement with Eli Lilly and Company to apply Fauna's...

Body Vision Medical announces distribution agreements for Argentina, Bolivia, Paraguay, Uruguay and Mexico Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced its exclusive distribution agreements with DeLeC Científica...

Absci, a generative AI drug creation company, and PrecisionLife®, a leading computational biology company driving precision medicine in complex chronic diseases, announced a collaboration...

ImmunoScape, a biotechnology company focused on the discovery and development of next-generation T cell receptor (TCR)-based therapeutics, and MiNK Therapeutics, Inc, a clinical stage biopharmaceutical...

Dxcover Limited, a clinical-stage diagnostics company pioneering Multi-Omic Spectral Analysis for early detection of multiple cancers, announced that Founder and newly announced CEO Matthew...

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that it has been included in a recent Gartner report,...

Owkin, a French-American biotechnology company that applies artificial intelligence (AI) to drug discovery, development, and diagnostics, announced that it has entered into a collaboration...